We are live on ! Find out more
HCM

Highbridge Capital Management Portfolio holdings

AUM $3.09B
1-Year Est. Return 31.21%
This Fund
S&P 500
This Quarter Est. Return
+0.53%
1 Year Est. Return
+31.21%
3 Year Est. Return
+54.52%
5 Year Est. Return
+78.37%
10 Year Est. Return
+191.37%
AUM
$2.45B
AUM Growth
+$45M
Cap. Flow
-$1.31B
Cap. Flow %
-53.22%
Top 10 Hldgs %
43.27%
Holding
417
New
29
Increased
24
Reduced
15
Closed
57

Sector Composition

Rank Sector Weight
1 Communication Services 5.01%
2 Healthcare 1.66%
3 Utilities 0.76%
4 Technology 0.39%
5 Real Estate 0.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAYAR
276
DELISTED
Bayview Acquisition Corp Right
BAYAR
$4.48K ﹤0.01%
+37,300
New +$4.48K
IGTAR
277
DELISTED
Inception Growth Acquisition Limited Rights
IGTAR
$4.37K ﹤0.01%
33,300
SHPWW
278
DELISTED
Shapeways Holdings, Inc. Warrants
SHPWW
0
VSACW
279
DELISTED
Vision Sensing Acquisition Corp. Warrants
VSACW
0
RCACW
280
DELISTED
Revelstone Capital Acquisition Corp. Warrant
RCACW
0
VIEWW
281
DELISTED
View, Inc. Warrant
VIEWW
0
CPTNW
282
DELISTED
Cepton, Inc. Warrant
CPTNW
0
GTACW
283
DELISTED
Global Technology Acquisition Corp. I Warrant
GTACW
0
THCPW
284
DELISTED
Thunder Bridge Capital Partners IV, Inc. Warrant
THCPW
0
FAZEW
285
DELISTED
FaZe Holdings Inc. Warrant
FAZEW
0
ABPWW
286
DELISTED
Abpro Holdings Warrant
ABPWW
0
LIDRW icon
287
AEye Inc Warrant
LIDRW
$69.2K
0
PPYAW
288
DELISTED
Papaya Growth Opportunity Corp. I Warrant
PPYAW
0
NSTB.WS
289
DELISTED
Northern Star Investment Corp. II Redeemable warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
NSTB.WS
0
TCOA.WS
290
DELISTED
Zalatoris Acquisition Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
TCOA.WS
0
AQUNR
291
DELISTED
Aquaron Acquisition Corp. Rights
AQUNR
$2.5K ﹤0.01%
10,000
ASCBW
292
DELISTED
A SPAC II Acquisition Corp. Warrant
ASCBW
0
HHGCR
293
DELISTED
HHG Capital Corporation Rights
HHGCR
$2.21K ﹤0.01%
17,314
NVACW
294
DELISTED
NorthView Acquisition Corporation Warrant
NVACW
0
PLMJW
295
DELISTED
Plum Acquisition Corp. III Warrant
PLMJW
0
BOCNW
296
DELISTED
Blue Ocean Acquisition Corp Warrants
BOCNW
0
GLSTR
297
DELISTED
Global Star Acquisition, Inc. Right
GLSTR
$1.56K ﹤0.01%
14,510
XFINW
298
DELISTED
ExcelFin Acquisition Corp Warrant
XFINW
0
ATMCR
299
DELISTED
AlphaTime Acquisition Corp Right
ATMCR
$1.01K ﹤0.01%
10,000
SRZNW icon
300
Surrozen Inc Warrant
SRZNW
$8.86K
0

Similar funds

Highbridge Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Highbridge Capital Management held 417 positions worth $2.45B, up 1.9% from $2.41B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Highbridge Capital Management withdrew a net $1.31B in Q4 2023, closing 57 positions and reducing 15 holdings. Its most notable exit was Seagen Inc. Common Stock, an estimated $19.3M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 5% of assets, up from 4.6% a quarter earlier, followed by Healthcare and Utilities.

Against the trend, Highbridge Capital Management opened a new position in Capri Holdings worth $8.29M.

  • Highbridge Capital Management's largest Q4 2023 buy was Capri Holdings: 165,000 shares worth $8.29M.
  • Highbridge Capital Management added most to Amedisys in Q4 2023, an estimated $14.5M increase.
  • Highbridge Capital Management's biggest Q4 2023 reduction was Brookdale Senior Living Inc. 7.00% Tangible Equity Units, cutting an estimated $14M.
  • Highbridge Capital Management fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $19.3M.
  • Highbridge Capital Management's ten largest holdings make up 43% of its $2.45B portfolio in Q4 2023.
  • Highbridge Capital Management opened 29 new positions and closed 57 in Q4 2023.
  • Highbridge Capital Management's portfolio value rose 1.9% quarter-over-quarter to $2.45B.

Based on Highbridge Capital Management's 13F filing for Q4 2023, filed 12 Feb 2024.